Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Science (New York, N.Y.)
|
September 3, 1971
On paradigms
W J Fraser
Science (New York, N.Y.)
|
October 25, 1974
Letters to the editor
W J Fraser
Histopathology
|
November 1, 1995
Rheumatic Aschoff nodules revisited: an immunohistological reappraisal of the cellular component
W J Fraser, Z Haffejee, K Cooper
American Journal of Human Biology : the Official Journal of the Human Biology Council
|
May 19, 2017
Search for secular trends in calvarial diameters, cranial base height, indices, and capacity in South African Negro crania
N Cameron, P V Tobias, W J Fraser, et al.
Histopathology
|
January 7, 1998
Rheumatic Aschoff nodules revisited. II: Cytokine expression corroborates recently proposed sequential stages
W J Fraser, Z Haffejee, D Jankelow, et al.
American Industrial Hygiene Association Journal
|
January 1, 1996
Performance-based exposure control limits for pharmaceutical active ingredients
B D Naumann, E V Sargent, B S Starkman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Science (New York, N.Y.)
|
September 3, 1971
On paradigms
W J Fraser
Science (New York, N.Y.)
|
October 25, 1974
Letters to the editor
W J Fraser
Histopathology
|
November 1, 1995
Rheumatic Aschoff nodules revisited: an immunohistological reappraisal of the cellular component
W J Fraser, Z Haffejee, K Cooper
American Journal of Human Biology : the Official Journal of the Human Biology Council
|
May 19, 2017
Search for secular trends in calvarial diameters, cranial base height, indices, and capacity in South African Negro crania
N Cameron, P V Tobias, W J Fraser, et al.
Histopathology
|
January 7, 1998
Rheumatic Aschoff nodules revisited. II: Cytokine expression corroborates recently proposed sequential stages
W J Fraser, Z Haffejee, D Jankelow, et al.
American Industrial Hygiene Association Journal
|
January 1, 1996
Performance-based exposure control limits for pharmaceutical active ingredients
B D Naumann, E V Sargent, B S Starkman, et al.
Page
of 1